Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Mario Negri Institute for Pharmacological Research

InstitutionResearch output, impact & collaborations

Mario Negri Institute for Pharmacological Research is a research organisation in Milan, IT. OpenAlex records 20,758 works and 5,406,427 citations for it. 2,622 researchers list it as their most recent affiliation.

20,758
Works
5,406,427
Citations
2,622
Researchers
74.8
Avg h-index

How has Mario Negri Institute for Pharmacological Research's publication output changed over time?

ScholarIQpublication output · 2000–2010

Output grew100% over the shown period — from 1 works in 2000 to 2 in 2010.

1
2
1
1
2
3
2
2000200120032006200820092010

Who are the most-cited researchers behind Mario Negri Institute for Pharmacological Research?

ScholarIQtop researchers by citations
1
Giuseppe Remuzzi · Renal Diseases and Glomerulopathies
2,091 works323,461 citations
2
Norberto Perico · Renal Transplantation Outcomes and Treatments
523 works217,184 citations

What are the most-cited papers on Mario Negri Institute for Pharmacological Research?

ScholarIQmost cited works
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
Barry M. Brenner, Mark E. Cooper, Dick de Zeeuw, William F. Keane, William E. Mitch, Hans‐Henrik Parving, Giuseppe Remuzzi, Steven Snapinn, Zhonxin Zhang, Shahnaz Shahinfar
New England Journal of Medicine. 20017,516 CitationsOPEN ACCESS
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
Kenneth Dickstein, Authors Task Force Members, A Cohen-Solal, Gerasimos Filippatos, John J.V. McMurray, Piotr Ponikowski, Philip A. Poole‐Wilson, Anna Strömberg, Dirk J. van Veldhuisen, Dan Atar, Arno W. Hoes, Andre Keren, Alexandre Mebazaa, Markku S. Nieminen, Silvia G. Priori, Karl Swedberg, Alec Vahanian, A. John Camm, Raffaele De Caterina, Verónica Dean, Kenneth Dickstein, Gerasimos Filippatos, C. Funck-Brentano, Irene Hellemans, Steen Dalby Kristensen, Keith McGregor, Udo Sechtem, Sigmund Silber, Michał Tendera, Petr Widimský, José Luis Zamorano, Michał Tendera, Document Reviewers, Angelo Auricchio, Jeroen J. Bax, Michael Böhm, Ugo Corrà, Paolo Della Bella, Perry Elliott, Ferenc Folláth, Mihai Gheorghiade, Yonathan Hasin, Anders Hernborg, Tiny Jaarsma, Michel Komajda, Ran Kornowski, Massimo Piepoli, Bernard Prendergast, Luigi Tavazzi, Jean-Luc Vachiery, Freek W.A. Verheugt, José Luis Zamorano, Faı̈ez Zannad
European Journal of Heart Failure. 20083,523 Citations
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
Jay N. Cohn, Gianni Tognoni
New England Journal of Medicine. 20013,106 CitationsOPEN ACCESS
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
Jean‐Pierre Pignon, Hélène Tribodet, Giorgio V. Scagliotti, Jean-Yves Douillard, Frances A. Shepherd, Richard Stephens, Ariane Dunant, Valter Torri, Rafael Rosell, Lesley Seymour, Stephen Spiro, Estelle Rolland, Roldano Fossati, D. Aubert, Keyue Ding, David Waller, Thierry Le Chevalier
Journal of Clinical Oncology. 20082,693 CitationsOPEN ACCESS
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Naveed Sattar, David Preiss, Heather Murray, Paul Welsh, Brendan M. Buckley, Anton JM de Craen, Sreenivasa Rao Kondapally Seshasai, John J.V. McMurray, Dilys J. Freeman, J. Wouter Jukema, Peter W. Macfarlane, Chris J. Packard, David J. Stott, Rudi G. J. Westendorp, James Shepherd, Barry R. Davis, Sara Pressel, Roberto Marchioli, Rosa Maria Marfisi, Aldo P. Maggioni, Luigi Tavazzi, Gianni Tognoni, John Kjekshus, Terje R. Pedersen, Thomas J. Cook, Antonio M. Gotto, Michael Clearfield, John R. Downs, Haruo Nakamura, Yasuo Ohashi, Kyoichi Mizuno, Kausik K. Ray, Ian Ford
The Lancet. 20102,456 Citations

How much of the research on Mario Negri Institute for Pharmacological Research is open access?

ScholarIQopen access share
75%OPEN ACCESS
Gold
0%
Green
8%
Hybrid
0%
Bronze
67%
Closed
25%

Related on ScholarIQ

Neuroscience and Neuropharmacology Research
Top Topic
Computational Drug Discovery Methods
Top Topic
Neurotransmitter Receptor Influence on Behavior
Top Topic
Renal Diseases and Glomerulopathies
Top Topic
Epilepsy research and treatment
Top Topic
Health Systems, Economic Evaluations, Quality of Life
Top Topic
470M+ articles · free account